Autoradiographic Distribution and Applied Pharmacological Characteristics of Dextromethorphan and Related Antitissue/Anticonvulsant Drugs and Novel Analogs

Abstract

The objective of this project is to investigate the potential significance of the neuroprotective agent dextromethorphan, and its receptor, in normal and abnormal brain. Dextromethorphan is a non-opioid cough suppressant. It is as potent as codeine, but has the opposite steric configuration (i.e., it is dextrorotatory rather than levorotatory), and possesses none of the CNS pharmacology normally associated with opioids. The demonstration in 1981 of high affinity binding sites for dextromethorphan, which were distinct from any known neurotransmitter or neuromodulator sites, was followed by the discovery that dextromethorphan also possessed significant anticonvulsant and neuroprotective properties.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 01, 1991
Accession Number
ADA243953

Entities

People

  • Bowery
  • Kathryn Bevan

Organizations

  • University of London

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Alkenes
  • Analogs
  • Anticonvulsants
  • Arteries
  • Biomedical Research
  • Cells
  • Drug Abuse
  • Filters
  • Health Services
  • Materials
  • Neuroprotective Drugs
  • Opioids
  • Pharmacies
  • Pharmacology
  • Rodents

Fields of Study

  • Medicine

Readers

  • Child and Adolescent Substance Abuse Science in Autism Spectrum Disorders.
  • Neuroscience
  • Toxicology/Environmental Toxicology

Technology Areas

  • Biotechnology